Oct 26, 2023 | NEWS
A large international study led by deCODE Genetics on the genetics of migraine provides novel insights into the biology of migraine enabling detection of rare variants protecting against migraine, opening an avenue for potential development of novel drug targets. In a...
Oct 4, 2023 | NEWS
In a paper released today, deCODE Genetics’ scientists shared their findings from a plasma proteomics study performed using affinity-based methods. They analyzed the proteins in the context of diseases and diversity in the sequence of the genome and compared...
Sep 14, 2023 | NEWS
Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from the Icelandic healthcare system and Copenhagen University, published a study today in the journal Cell titled “Complex effects of sequence variants on lipid levels and coronary artery...
Aug 22, 2023 | NEWS
deCODE genetics and its collaborators employed AI to develop a protein score to predict major atherosclerotic cardiovascular disease events In a large retrospective analysis using measurements of thousands of plasma proteins in primary and secondary event populations,...
Aug 16, 2023 | NEWS
Scientists at deCODE genetics, a subsidiary of Amgen, in collaboration with scientists at the National University Hospital of Iceland, have uncovered thirty novel sequence variants impacting human intracranial volume. In the study, recently published, in the journal...
Jul 26, 2023 | NEWS
Scientists at deCODE genetics, a subsidiary of Amgen, in collaboration with researchers at the National University Hospital of Iceland, have published a study on a cardiac electrical abnormality that can potentially result in sudden cardiac death. The study, recently...
